AMLX SG&A Expense Growth
Amylyx Pharmaceuticals Inc · SG&A Expense Growth
AMLX SG&A Expense Growth
Latest reported-45.00%period ending
AMLX FY SG&A Growth (YoY) (0.00% → -45.00%)
Latest values, visible window
High-resolution chart · PNG
AMLX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -44.9957% | |
| -39.3006% | |
| 48.1625% | |
| 226.5302% | |
| 158.5021% | |
| 388.8348% | |
| 0% |